Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Scilex Holding Company (SCLXW)

Compare
0.1001
-0.0379
(-27.46%)
At close: March 28 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
55,152
46,743
38,034
31,317
23,560
Cost of Revenue
16,519
15,681
10,797
3,634
2,149
Gross Profit
38,633
31,062
27,237
27,683
21,411
Operating Expense
121,381
136,493
77,871
63,521
56,669
Operating Income
-82,748
-105,431
-50,634
-35,838
-35,258
Net Non Operating Interest Income Expense
-2,229
-1,068
-9,604
-39,764
-13,116
Other Income Expense
-2,762
-7,819
36,878
-12,817
802
Pretax Income
-87,739
-114,318
-23,360
-88,419
-47,572
Tax Provision
8
13
4
5
-53
Net Income Common Stockholders
-140,392
-166,976
-23,364
-88,424
-47,519
Diluted NI Available to Com Stockholders
-140,392
-166,976
-23,364
-88,424
-47,519
Total Operating Income as Reported
-73,357
-105,431
-50,634
-35,838
-35,258
Total Expenses
137,900
152,174
88,668
67,155
58,818
Net Income from Continuing & Discontinued Operation
-87,747
-114,331
-23,364
-88,424
-47,519
Normalized Income
-97,377.8900
-113,833.3000
-52,497.6200
-79,067.5900
-48,319.3960
Interest Expense
2,229
1,068
9,604
39,764
13,116
Net Interest Income
-2,229
-1,068
-9,604
-39,764
-13,116
EBIT
-85,510
-113,250
-13,756
-48,655
-34,456
EBITDA
-81,434
-109,104
-9,795
-44,876
-30,679
Reconciled Cost of Revenue
16,499
15,641
10,758
3,593
2,110
Reconciled Depreciation
4,076
4,146
3,961
3,779
3,777
Net Income from Continuing Operation Net Minority Interest
-87,747
-114,331
-23,364
-88,424
-47,519
Total Unusual Items Excluding Goodwill
12,191
-630
36,878
-12,817
802
Total Unusual Items
12,191
-630
36,878
-12,817
802
Normalized EBITDA
-93,625
-108,474
-46,673
-32,059
-31,481
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0
Tax Effect of Unusual Items
2,560.1100
-132.3000
7,744.3800
-3,460.5900
1.6040
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EH3A.F Amarin Corporation plc
0.3500
-2.23%
 
AMRN Amarin Corporation plc
0.4420
-1.36%
 
GSK.L GSK plc
1,423.00
-3.13%
 
GSK GSK plc
37.87
-2.25%
 
GILD Gilead Sciences, Inc.
111.28
-0.69%
 
LLY Eli Lilly and Company
805.23
-2.50%
 
NOVO-B.CO Novo Nordisk A/S
467.95
-2.31%
 
NVO Novo Nordisk A/S
68.03
-2.03%
 
MRK Merck & Co., Inc.
87.12
-2.94%
 
JNJ Johnson & Johnson
153.25
-7.59%